Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–62.

Article  CAS  PubMed  Google Scholar 

Lee TK-W, Guan X-Y, Ma S. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications. Nat Rev Gastroenterol Hepatol. 2022;19(1):26–44.

Article  PubMed  Google Scholar 

Sankar K, Gong J, Osipov A, Miles SA, Kosari K, Nissen NN, Hendifar AE, Koltsova EK, Yang JD. Recent advances in the management of hepatocellular carcinoma. Clin Mol Hepatol. 2024;30(1):1–15.

Article  PubMed  Google Scholar 

Rizzo A, Ricci AD, Brandi G. Trans-arterial chemoembolization plus systemic treatments for hepatocellular carcinoma: an update. J Pers Med. 2022;12(11):1788.

Article  PubMed  PubMed Central  Google Scholar 

Bent EH, Wehrenberg-Klee E, Koay EJ, Goyal L, Wo JY. Integration of systemic and liver-directed therapies for locally advanced hepatocellular cancer: harnessing potential synergy for new therapeutic horizons. J Natl Compr Canc Netw. 2021;19(5):567–76.

Article  CAS  PubMed  Google Scholar 

Rizzo A, Ricci AD, Brandi G. Atezolizumab in advanced hepatocellular carcinoma: good things come to those who wait. Immunotherapy. 2021;13(8):637–44.

Article  CAS  PubMed  Google Scholar 

Shen K-Y, Zhu Y, Xie S-Z, Qin L-X. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives. J Hematol Oncol. 2024;17(1):25.

Article  PubMed  PubMed Central  Google Scholar 

Pinter M, Scheiner B, Peck-Radosavljevic M. Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups. Gut. 2021;70(1):204–14.

Article  CAS  PubMed  Google Scholar 

Lv Z, Yue Z, Shao Y, Li C, Zhao X, Guo M. mTORC2/Rictor is essential for coelomocyte endocytosis in Apostichopus japonicus. Dev Comp Immunol. 2021;118: 104000.

Article  CAS  PubMed  Google Scholar 

Qiao R, Xiao R, Chen Z, Jiang J, Yuan C, Ning S, Wang J, Zhou Z. Cloning, expression and inhibitory effects on lewis lung carcinoma cells of rAj-Tspin from sea cucumber (Apostichopus japonicus). Molecules (Basel Switzerland). 2021;27(1):229.

Article  PubMed  Google Scholar 

Casal JI, Bartolomé RA. RGD cadherins and α2β1 integrin in cancer metastasis: a dangerous liaison. Biochim Biophys Acta Rev Cancer. 2018;1869(2):321–32.

Article  CAS  PubMed  Google Scholar 

Sheikh A, Md S, Kesharwani P. RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy. J Control Release. 2021;340:221–42.

Article  CAS  PubMed  Google Scholar 

Yu P, Wu R, Zhou Z, Zhang X, Wang R, Wang X, Lin S, Wang J, Lv L. rAj-Tspin, a novel recombinant peptide from Apostichopus japonicus, suppresses the proliferation, migration, and invasion of BEL-7402 cells via a mechanism associated with the ITGB1-FAK-AKT pathway. Invest New Drugs. 2021;39(2):377–85.

Article  CAS  PubMed  Google Scholar 

He M, Zhou Z, Wu G, Chen Q, Wan Y. Emerging role of DUBs in tumor metastasis and apoptosis: therapeutic implication. Pharmacol Ther. 2017;177:96–107.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong C, Yu J, Li D, Jiang K, Tang Y, Yang M, Shen H, Fang X, Ding K, Zheng S, Yuan Y. Zyxin as a potential cancer prognostic marker promotes the proliferation and metastasis of colorectal cancer cells. J Cell Physiol. 2019;234:15775–89.

Article  CAS  PubMed  Google Scholar 

Partynska A, Gomulkiewicz A, Piotrowska A, Grzegrzolka J, Rzechonek A, Ratajczak-Wielgomas K, Podhorska-Okolow M, Dziegiel P. Expression of zyxin in non-small cell lung cancer-a preliminary study. Biomolecules. 2022;12(6):827.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen X-M, Luo T, Jiang Y, Wang L-H, Luo Y, Chen Q, Yang K, Yuan Y, Luo C, Zhang X, Yan Z-X, Fu W-J, Tan Y-H, Niu Q, Xiao J-F, Chen L, Wang J, Huang J-F, Cui Y-H, Zhang X, Wang Y, Bian X-W. Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme. Lab Invest. 2020;100(6):812–23.

Article  CAS  PubMed  Google Scholar 

Paluch EK, Aspalter IM, Sixt M. Focal adhesion-independent cell migration. Annu Rev Cell Dev Biol. 2016;32:469–90.

Article  CAS  PubMed  Google Scholar 

Seong J, Wang N, Wang Y. Mechanotransduction at focal adhesions: from physiology to cancer development. J Cell Mol Med. 2013;17(5):597–604.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Z-J, Dai H-Q, Huang X-W, Feng J, Deng J-H, Wang Z-X, Yang X-M, Liu Y-J, Wu Y, Chen P-H, Shi H, Wang J-G, Zhou J, Lu G-D. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301–10.

Article  CAS  PubMed  Google Scholar 

El-Shemi AG, Ashshi AM, Na Y, Li Y, Basalamah M, Al-Allaf FA, Oh E, Jung B-K, Yun C-O. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model. J Exp Clin Cancer Res. 2016;35:74.

Article  PubMed  PubMed Central  Google Scholar 

Xu X-F, Xing H, Han J, Li Z-L, Lau W-Y, Zhou Y-H, Gu W-M, Wang H, Chen T-H, Zeng Y-Y, Li C, Wu M-C, Shen F, Yang T. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg. 2019;154(3):209–17.

Article  PubMed  Google Scholar 

Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1–61.

Article  CAS  PubMed  Google Scholar 

Chen Y, Chen H-N, Wang K, Zhang L, Huang Z, Liu J, Zhang Z, Luo M, Lei Y, Peng Y, Zhou Z-G, Wei Y, Huang C. Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. J Hepatol. 2019;70(1):66–77.

Article  CAS  PubMed  Google Scholar 

Liu D, Song T. Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China. Biosci Trends. 2021;15(3):142–7.

Article  PubMed  Google Scholar 

Li T, Zhou T, Liu Y, Wang J, Yu Z. Efficacy analysis of targeted nanodrug for non-small cell lung cancer therapy. Front Bioeng Biotechnol. 2022;10:1068699.

Article  PubMed  PubMed Central  Google Scholar 

Fu S, Xu X, Ma Y, Zhang S, Zhang S. RGD peptide-based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy. J Drug Target. 2019;27:1–11.

Article  CAS  PubMed  Google Scholar 

Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.

Article  PubMed  PubMed Central  Google Scholar 

Eke I, Cordes N. Focal adhesion signaling and therapy resistance in cancer. Semin Cancer Biol. 2015;31:65–75.

Article  CAS  PubMed  Google Scholar 

Liao S, Chen H, Liu M, Gan L, Li C, Zhang W, Lv L, Mei Z. Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway. Aging (Albany NY). 2020;12(2):1527–44.

Article  CAS